MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically

Journal: Nature Communications

Published: 2020-09-10

DOI: 10.1038/s41467-020-18372-1

Affiliations: 31

Authors: 37

Go to article
Institutions Share
TUM Department of Internal Medicine III (Hematooncology/Oncology), Germany 0.20
TUM Institute of Pathology, Germany 0.12
German Consortium of Translational Cancer Research (DKTK), Germany 0.08
TUM Center for Translational Cancer Research (TranslaTUM), Germany 0.06
TUM Department of Diagnostic and Interventional Neuroradiology, Germany 0.05
CRUK Lung Cancer Centre of Excellence, United Kingdom (UK) 0.04
TUM School of Medicine, Germany 0.03
TUM Institute of Molecular Immunology and Experimental Oncology (IMI), Germany 0.03
TUM Chair of Biomedical Physics (E17), Germany 0.03
TUM Munich School of Bioengineering (MSB), Germany 0.03
Division of Chronic Inflammation and Cancer, DKFZ, Germany 0.03
Institute of Pathology at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.03
TUM University Hospital Klinikum rechts der Isar (MRI), Germany 0.03
Institute of Lung Biology and Disease (iLBD), CPC-M, Germany 0.03
Laboratory for Molecular Respiratory Carcinogenesis (LMRC), University of Patras, Greece 0.03
MERLN Institute for Technology-Inspired Regenerative Medicine, UM, Netherlands 0.03
UCL Cancer Institute, United Kingdom (UK) 0.02
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.02
TUM Department of Internal Medicine II (Gastroenterology), Germany 0.02
Department of Medical Biology, UniMelb, Australia 0.01
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia 0.01
Translational Lung Research Center Heidelberg (TLRC), Germany 0.01
TUM Biobank, Germany 0.01
National Center for Tumor Diseases (NCT) Heidelberg, Germany 0.01
Thoraxklinik Universitätsklinikum Heidelberg, Uni Heidelberg, Germany 0.01
Faculty of Biosciences, Uni Heidelberg, Germany 0.01
Division of Applied Bioinformatics, DKFZ, Germany 0.01
Division of Oncology, Med Uni Graz, Austria 0.01